Zobrazeno 1 - 10
of 32
pro vyhledávání: '"J. Cox Gill"'
Autor:
T C, Abshire, A B, Federici, M T, Alvárez, J, Bowen, M D, Carcao, J, Cox Gill, N S, Key, P A, Kouides, K, Kurnik, A E, Lail, F W G, Leebeek, M, Makris, P M, Mannucci, R, Winikoff, E, Berntorp, T, Yee
Publikováno v:
Haemophilia, 19(1), 76-81. Wiley-Blackwell Publishing Ltd
The bleeding patterns of severe von Willebrand’s disease (VWD) adversely affect quality of life, and may be life threatening. There is a presumed role for prophylaxis with VWF-containing concentrates, but data are scarce. The von Willebrand Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f40016e3dbb6a4bfddc1658477a53575
https://doi.org/10.1111/j.1365-2516.2012.02916.x
https://doi.org/10.1111/j.1365-2516.2012.02916.x
Autor:
J. Cox Gill, Qizhen Shi, Erin L. Kuether, Jocelyn A. Schroeder, Robert R. Montgomery, Scot A. Fahs, C. L. Perry
Publikováno v:
Journal of Thrombosis and Haemostasis. 10:2328-2337
Summary. Background: The important association between von Willebrand factor (VWF) and factor VIII (FVIII) has been investigated for decades, but the effect of VWF on the reactivity of FVIII inhibitory antibodies, referred to as inhibitors, is still
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7220dfbd15dd6d36dfcc7b42e29cd8ae
https://doi.org/10.1111/j.1538-7836.2012.04902.x
https://doi.org/10.1111/j.1538-7836.2012.04902.x
Autor:
Amy L. Dunn, J. Cox Gill
Publikováno v:
Haemophilia. 16:711-716
Summary. Many patients with mild inherited bleeding disorders such as von Willebrand disease (VWD), mild haemophilia A (HA) and platelet function defects (PFD) undergo adenoidectomy and/or tonsillectomy (AT) procedures each year. Management of bleedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aec4fa4ebebc8d557b536d486d9a194f
https://doi.org/10.1111/j.1365-2516.2009.02145.x
https://doi.org/10.1111/j.1365-2516.2009.02145.x
Autor:
Thomas C. Abshire, Manuel Carcao, Erik Berntorp, Frank W.G. Leebeek, Peter A. Kouides, Sharyne Donfield, J. Cox-Gill, Christine L. Kempton
Publikováno v:
Journal of Thrombosis and Haemostasis, 13(9), 1585-1589. Wiley-Blackwell Publishing Ltd
BackgroundTreatment of mucosal bleeding (epistaxis, gastrointestinal bleeding, and menorrhagia) and joint bleeding remains problematic in clinically severe von Willebrand disease (VWD). Patients are often unresponsive to treatment (e.g. desmopressin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44035cfd3d12de3455914bc3d16db95f
https://pubmed.ncbi.nlm.nih.gov/26081061
https://pubmed.ncbi.nlm.nih.gov/26081061
Publikováno v:
Haemophilia. 9:688-695
This prospective, open-label, non-randomized study evaluated the safety and efficacy of factor VIII (FVIII)/von Willebrand Factor (VWF) concentrate (Humate-P) using treatment regimens based on VWF:ristocetin cofactor (VWF:RCo) activity in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d126e554207d9a53f28f98d16dd83fa8
https://doi.org/10.1046/j.1351-8216.2003.00816.x
https://doi.org/10.1046/j.1351-8216.2003.00816.x
Publikováno v:
Haemophilia. 7:258-266
An open-label multicentre trial was conducted to evaluate high-dose DDAVP (desmopressin acetate) intranasal spray (Stimate; 1.5 mg mL(-1)), for the control of bleeding in 333 patients with mild haemophilia A, mild or moderate type 1 von Willebrand di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc7fdc400941ee1f88422b738c6ba70
https://doi.org/10.1046/j.1365-2516.2001.00500.x
https://doi.org/10.1046/j.1365-2516.2001.00500.x
Autor:
A L, Dunn, J, Cox Gill
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 16(5)
Many patients with mild inherited bleeding disorders such as von Willebrand disease (VWD), mild haemophilia A (HA) and platelet function defects (PFD) undergo adenoidectomy and/or tonsillectomy (AT) procedures each year. Management of bleeding in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d6542c8ee72575bd1d37d8ed24922a02
https://pubmed.ncbi.nlm.nih.gov/20028423
https://pubmed.ncbi.nlm.nih.gov/20028423
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 9(6)
This prospective, open-label, non-randomized study evaluated the safety and efficacy of factor VIII (FVIII)/von Willebrand Factor (VWF) concentrate (Humate-P) using treatment regimens based on VWF:ristocetin cofactor (VWF:RCo) activity in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8870bb7ae03aa5539a378337776796d5
https://pubmed.ncbi.nlm.nih.gov/14750934
https://pubmed.ncbi.nlm.nih.gov/14750934
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.